
Dr Philip Robinson 🇺🇦
@philipcrobinson
Rheumatologist & UQ Associate Professor; rheum-covid.org; @UQ_news @MetroNorthHHS; Please stay safe out there
ID: 246959615
https://researchers.uq.edu.au/researcher/11395 03-02-2011 20:22:09
9,9K Tweet
4,4K Followers
541 Following


Cumulative dose and exposure to methotrexate were not predictors of hepatic fibrosis. Hepatic fibrosis as measured by elastography associated with daily EtOH use. #ACRBest Abs#2147 Dr. John Cush #ACR22

Can you put a bit of morphine intraarticularly inside an osteoarthritic knee and make it better? Cute idea, no bingo. I get that we're chasing better symptomatic solutions, but... Don't do this. ABST1833 #ACR22 Dr. John Cush


Super interesting: safer steroids? Molecule (SPI-62) being trialled in PMR pts now (n=48) In mice, normalizes glucocorticosteroid toxicty: - didn't put on weight - skin didn't thin For PMR pts stuck on PNL for months, very enticing. Watch this space! ABST1549 #ACR22 Dr. John Cush


You're on a JAKi for RA, & you get shingles. If you continue the JAKi, are you more likely to get shingles again? Korean🇰🇷 national insurance data, HZ recurrence: no difference true for all relevant subgroups Don't let HZ get in the way of a good JAKi ABST2220 #ACR22 Dr. John Cush


Just released in The Journal of Rheumatology! Our paper is on gout flare during COVID-19 hospitalization. Very proud of our team: Satpanich P. Prof Rebecca Grainger Dr Philip Robinson 🇺🇦 jrheum.org/content/early/…

Very happy to have Dr. Philip Robinson Dr Philip Robinson 🇺🇦 from UQ News in a special seminar on #COVID19 today. Welcome Dr. Robinson! UAB Medicine UAB


Gennie Wang, MD All: Farmer came in willingly.

Interesting study showing studies need to report more detail in patient characteristics to allow better information about vaccine efficacy in potentially vulnerable populations samwhittle Rachelle Buchbinder Dr Philip Robinson 🇺🇦

Valuable drug while it lasted- we now must push FDA to fast rack access to new active MoAbs Paul Sax Carlos del Rio Cassandra Calabrese Alfred Kim (moving to Bluesky as alhkim) Evusheld, aggressive therapy may reduce #COVID19 severity in patients on B-cell depletion healio.com/news/rheumatol…


Leonard Calabrese Thanks for sharing! For the general audience: since everyone's first question re: PD-1 agonism is about cancer risk, it's a good time to say... it's complicated. (Also, amongst many things written, this nice review from Dennis McGonagle sciencedirect.com/science/articl…, featuring this)



Accepted for publication: A systematic review of neuromyopathy associated with colchicine use: - risk factors: renal or hepatic dysfunction or meds that inhibit P450 - colchicine cessation typically resolves symptoms Tim McEwan Dr Philip Robinson 🇺🇦 sciencedirect.com/science/articl…

Lucina Uddin Go on to my “dashboard” and complete all my outstanding e-training modules


